ERS International Congress, Madrid 2019

Browse by day: Saturday, 28.09.2019 Sunday, 29.09.2019 Monday, 30.09.2019 Tuesday, 01.10.2019 Wednesday, 02.10.2019		View the presentations you missed during Congress! More than 1,000 webcasts and slide presentations, 1,900 e-posters and 4,200 abstracts from the International Congress in Madrid and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2019; 54: Suppl. 63, abstract number.

New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside

Hot topic
Chairs: J. Hedner (Göteborg, Sweden), M. Bonsignore (Palermo, Italy)
Aims: to describe the control of hypoglossal motor activity across sleep-wake states and identification of pharmacological targets in a preclinical model; to describe the results of the first successful clinical trial of pharmacological therapy for obstructive sleep apnoea; to describe the role of leptin in upper airway motor control in obesity and the potential therapeutic implications; to describe clinical and translational data regarding the effect of carbon anhydrase inhibitors on sleep-disordered breathing.

Download all media

Control of hypoglossal motor activity across sleep-wake states and identification of pharmacological targets R. Horner (Toronto (ON), Canada)
Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea L. Taranto Montemurro (Chestnut Hill , United States of America)
Can leptin be used to treat obstructive sleep apnoea? V. Polotsky (Baltimore, United States of America)
Carbon anhydrase inhibitors for treatment of obstructive sleep apnoea J. Hedner (Göteborg, Sweden)